(Q56864484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Allergen-induced bronchial eosinophilia in guinea-pigs is inhibited by both pre- and post-induction cyclosporin-A treatments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

C I Ezeamuzie

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R N Nwankwoala

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunopharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

515-522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Biological effects of cyclosporin A: A new antilymphocytic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3)

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Inhibition of antigen-induced late asthmatic response and bronchial hyperresponsiveness by cyclosporin and FK 506.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

The eosinophil and the pathophysiology of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

The eosinophilic leukocyte: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900015-1

7 January 2021

10.1016/S0192-0561(00)00015-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10785548%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference